Top Markets
#1 Nesa Nesa +833.90%
#2 Merlin's Seal BTC Merlin's Seal BTC +46.02%
#3 EXOD EXOD +22.78%
#4 Prom Prom +12.83%
#5 Fartcoin Fartcoin +11.24%
#6 Venom Venom +11.01%
#7 Cash Cat Cash Cat +9.69%
#8 Stacks Stacks +9.38%
#9 Pons Pons +9.23%
#10 PondCoin PondCoin +9.04%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ImmunoGen, Inc. ImmunoGen, Inc.

ImmunoGen, Inc.

IMGN
Rang in aandelen #3083
ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes... ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes in the creation of antibody-drug conjugate (ADC) therapies for cancer treatment. A prominent drug in their pipeline is mirvetuximab soravtansine, an ADC designed to target folate-receptor alpha (FRa), which is currently undergoing Phase III clinical trials for patients with platinum-resistant ovarian cancer. Another significant candidate, Pivekimab sunirine, a CD123-targeting ADC, is progressing through Phase II studies for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Beyond its clinical efforts, the company's preclinical portfolio includes IMGC936, an ADC being co-developed with MacroGenics, Inc., and IMGN151, another anti-FRa therapeutic. ImmunoGen maintains strategic collaborations with a range of key industry players, such as Roche, Amgen/Oxford BioTherapeutics, Bayer HealthCare AG, Eli Lilly and Company, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Fusion Pharmaceuticals Inc., Debiopharm International SA, and MacroGenics, Inc. Founded in 1980, ImmunoGen, Inc. is headquartered in Waltham, Massachusetts.
Aandeelprijs
$31.23
Laatst gesynchroniseerd: 2024-02-13
Marktkapitalisatie
$6.24B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel ImmunoGen, Inc. (IMGN)

Categorie

Healthcare
Dividendrendementgeschiedenis voor ImmunoGen, Inc. (IMGN)
Het dividendrendement (TTM) van ImmunoGen, Inc. (aandelsymbool: IMGN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van ImmunoGen, Inc. (IMGN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH